How We’re Mobilizing Our Resources to Help Find Solutions for Covid-19
Learn More
In light of current events taking place across the country, our Chairman and CEO sent this letter to the company's 135,000 global employees.
Doctors, nurses and other healthcare professionals are working tirelessly to treat patients infected with the novel coronavirus. To bolster their heroic efforts, the company committed $50 million to help organizations dedicated to helping them.
Imagine being a researcher who is staring down not only a highly infectious virus, but one that's caused the first global pandemic in more than 100 years. Meet Johnson & Johnson's Hanneke Schuitemaker, Ph.D.
At the height of the outbreak in New York City, Dr. Ed Kuffner took a leave of absence from his job to volunteer at a Brooklyn hospital hard hit by the pandemic. He shares what the experience taught him about his own strengths—and ideas for coping during this unprecedented time.
Johnson & Johnson has an expansive archive of existing drug compounds—and two researchers are leading the charge in combing through this molecular storehouse in pursuit of a possible breakthrough.
Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.
Live Video Series
The Road to a Vaccine
"The Road to a Vaccine" is a groundbreaking eight-episode series that explores the COVID-19 crisis and the urgent global efforts to develop a vaccine candidate to help fight the pandemic.
Episode 8
What Two Renowned Virus Hunters Want Us to Know About COVID-19
Virologist Peter Piot, M.D., Ph.D., talks with Paul Stoffels, M.D., about what it was like to personally battle COVID-19. World renowned expert Cato Laurencin, M.D., Ph.D., discusses why racism is a public health crisis. Plus, other coronavirus news.
Episode 1
Join host Lisa Ling as she interviews scientists and healthcare workers about how vaccines work, the impact of the COVID-19 pandemic and what’s being done globally to create a novel coronavirus vaccine.
How a COVID-19 Vaccine Might Work. Plus, How Quickly We Could Get There
How a COVID-19 Vaccine Might Work. Plus, How Quickly We Could Get There
Episode 2
Three leading scientists who have been on the frontlines of Zika, malaria and HIV give you the inside scoop on vaccine development and the process of going from lab to clinic.
What it Takes to Create a Coronavirus Vaccine in Record Time
What it Takes to Create a Coronavirus Vaccine in Record Time
Episode 3
Lisa Ling interviews National Academies member and University Professor at the University of Connecticut, Cato Laurencin, M.D., Ph.D., to learn what his new coronavirus study reveals. Plus, what’s needed to mass-produce a vaccine and what we’ve learned from other outbreaks.
Why is COVID-19 Hitting Minority Communities So Hard?
Why is COVID-19 Hitting Minority Communities So Hard?
Episode 4
This week we hear from two ER doctors about what they’ve learned from caring for COVID-19 patients. A renowned epidemiologist shares why testing is so important. A Nigerian doctor who recovered from Ebola herself talks about how fighting this outbreak is different. Plus, a leading scientist talks about how long vaccine immunity could last.
What Doctors On The Front Lines of COVID-19 Are Now Saying About the Virus
What Doctors On The Front Lines of COVID-19 Are Now Saying About the Virus
Episode 5
Two nurses—one on the front lines in the ICU, and one leading the charge to advocate for her profession—talk about what caring for patients, and each other, really means right now. An activist talks about recovering from the virus and a scientist shares the challenges of creating a vaccine for clinical. Plus, Arianna Huffington and Husseini K. Manji, MD, FRCPC, discuss the other COVID-19 crisis: how it's impacting mental health.
How Nurses Are Battling the COVID-19 Pandemic
How Nurses Are Battling the COVID-19 Pandemic
Episode 6
Lisa Ling speaks with the Chair of the Coalition for Epidemic Preparedness Innovations, the head of Global Public Affairs at UPS, and other experts about what it will take to get a vaccine to the people who need it. Plus, a young Nigerian activist on her outreach efforts.
How the Global Community is Coming Together to Battle COVID-19
How the Global Community is Coming Together to Battle COVID-19
Episode 7
In Episode 7, Lisa Ling speaks with Johnson & Johnson Chief Scientific Officer Paul Stoffels, M.D., about important advances being made in vaccine development. Former FDA Commissioner Mark McClellan, M.D., Ph.D., discusses what reopening could look like and global health leader Jonathan Quick, M.D., MPH, shares why he believes testing is critical to help manage this pandemic.
What Our “New Normal” Might Look Like Until We Get a COVID-19 Vaccine
What Our “New Normal” Might Look Like Until We Get a COVID-19 Vaccine
-
What You're Talking About
-
Fact
Johnson & Johnson has a long history of supporting military veterans and servicemembers—a legacy that can be traced as far back as the Civil War.
Recent Johnson & Johnson Initiatives in the Spotlight
Learn more about the company’s latest groundbreaking programs, game-changing innovations and global partnerships—all aimed at helping change the trajectory of health for humanity.
